Vivos Therapeutics Inc. (VVOS): Price and Financial Metrics
GET POWR RATINGS... FREE!
VVOS Stock Price Chart Interactive Chart >
VVOS Price/Volume Stats
|Current price||$4.94||52-week high||$14.41|
|Prev. close||$5.68||52-week low||$4.88|
|Day high||$5.67||Avg. volume||184,528|
|50-day MA||$6.52||Dividend yield||N/A|
|200-day MA||$0.00||Market Cap||112.69M|
Vivos Therapeutics Inc. (VVOS) Company Bio
Vivos Therapeutics, Inc., a medical technology company, engages in the development and commercialization of technology solutions for patients with sleep disordered breathing (SDB) comprising mild-to-moderate obstructive sleep apnea (OSA). The company's solutions cover proprietary alternatives for treating mild-to-moderate OSA; craniofacial and anatomical anomalies that are associated with mild-to-moderate OSA. Its treatment for OSA involves specially designed and customized oral appliances and treatment protocols. The company, through its Vivos Integrated Healthcare Network, provides access to healthcare providers for delivering care for patients suffering from sleep disordered breathing, including mild-to-moderate OSA. Vivos Therapeutics, Inc. also licenses its intellectual property to third-party manufacturers, which fabricate appliance devices for healthcare professionals. It caters to general dentists, medical doctors, myofunctional therapists, chiropractors, healthcare providers, and patients in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2007 and is based in Highlands Ranch, Colorado.
VVOS Latest News Stream
|Loading, please wait...|
VVOS Latest Social Stream
View Full VVOS Social Stream
Latest VVOS News From Around the Web
Below are the latest news stories about Vivos Therapeutics Inc that investors may wish to consider to help them evaluate VVOS as an investment opportunity.
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900 active prominent money managers and analyze their quarterly 13F filings. The stocks that are heavily bought by hedge funds historically outperformed the market, though there is no shortage of high profile […]
Vivos Therapeutics Founder & Chief Medical Officer Releases New Book Highlighting His Groundbreaking Work
HIGHLANDS RANCH, Colo., May 26, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from sleep-disordered breathing, including mild-to-moderate obstructive sleep apnea (OSA), today announced that the Company’s Founder and Chief Medical Officer, Dr. G. Dave Singh, DMD, Ph.D., DDSc., has released a new book to help doctors and dentists better understand how to address underlying craniofacial conditions that affect a patient’s overall airway, breathing and sleep health. Dr. Singh’s book, titled, Pneumopedics and Craniofacial Epigenetics, covers craniofacial growth and developmental genetics, and addresses the c...
Management to Host Conference Call Today at 5:00 pm ETHIGHLANDS RANCH, Colo., May 17, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from sleep-disordered breathing, including mild-to-moderate obstructive sleep apnea (OSA), today reported financial results and operating highlights for the first quarter ended March 31, 2021. Financial and Operating Highlights: Revenue was $3.4 million for the first quarter of 2021, an 8% increase compared to $3.2 million for the first quarter of 2020;Gross profit was $2.7 million for the first quarter of 2021, an 11% increase compared to gross profit of $2.4 million for t...
NEW YORK, NY / ACCESSWIRE / May 17, 2021 / Vivos Therapeutics Inc (NASDAQ:VVOS) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 17, 2021 at 5:00 PM Eastern Time.To listen to the event live or access a replay of the call - visit https://www.
The big shareholder groups in Vivos Therapeutics, Inc. ( NASDAQ:VVOS ) have power over the company. Institutions often...
VVOS Price Returns